Funding for this research was provided by:
National Institute for Health Research (RP-PG-0216-20003)
Article History
Received: 24 March 2022
Accepted: 28 September 2022
First Online: 8 October 2022
Declarations
:
: The PROSPER trial was reviewed and approved by the Bradford Leeds Research Ethics Committee, reference number 20/YH/0108.
: Not applicable.
: The authors declare that they have no competing interests.